J&J’s COVID vaccine is dead in the US; FDA revokes authorization
Jun 6, 2023 · The Food and Drug Administration has withdrawn authorization for Johnson & Johnson's COVID-19 vaccine, ending its short-lived but troubled existence amid the pandemic.
Joint CDC and FDA Statement on Johnson & Johnson COVID-19 …
Apr 13, 2021 · As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a...
Janssen COVID-19 Vaccine | FDA - U.S. Food and Drug Administration
Information about the Janssen COVID-19 Vaccine, manufactured by Janssen Biotech Inc., a Janssen Pharmaceutical Company of Johnson & Johnson
FDA and CDC Lift Recommended Pause on Johnson & Johnson …
Following a thorough safety review, including two meetings of the CDC’s Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for Disease...
Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA …
The Janssen COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized by FDA through an Emergency Use Authorization (EUA) for active immunization to prevent Coronavirus Disease 2019 (COVID-19) in individuals 18 years of age and older.
FDA puts strict limits on Johnson & Johnson Covid-19 vaccine
May 5, 2022 · The US Food and Drug Administration announced Thursday that it is limiting the emergency use authorization of the Johnson & Johnson/Janssen Covid-19 vaccine to people 18 and older for whom...
Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized …
Oct 20, 2021 · NEW BRUNSWICK, N.J., October 20, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for a booster dose of the Johnson & Johnson COVID-19 vaccine for adults aged 18 and older at least two months following primary vaccination with single ...
Johnson & Johnson COVID-19 Vaccine Booster Shot …
Oct 15, 2021 · Johnson & Johnson COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee Recommendation informed by Phase 3 findings showing a booster increased protection to 94 percent against moderate to severe/critical COVID-19 in the U.S.
FDA approves standalone use of J&J’s ketamine-derived ... - CNN
2 days ago · The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the ...
J&J's subcutaneous Rybrevant, AZ's Andexxa are rejected by FDA
Dec 17, 2024 · Johnson & Johnson has received coal in its stocking from the FDA as manufacturing issues have tripped up the company’s attempt to gain approval of its subcutaneous version of lung cancer drug...